Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immune response in infants after primary vaccination with Tritanrix-HepB mixed with three Hib-MenAC vaccine formulations; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Meningococcal Disease
• Pertussis
• Tetanus

Drugs mentioned

• Hib-MenAC (Haemophilus influenzae type b plus Neisseria meningitidis serogroups A and C vaccine)
• Tritanrix-HepB (Diphtheria, Tetanus, and Hepatitis B vaccine (adsorbed))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Tetanus | Phase 2 | Status: COMPLETED